Option Care Health Stock

Option Care Health P/S

The (Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. of Option Care Health (OPCH) as of Aug 1, 2026 is 0.76. In the previous year, (Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. was 0.86 — a change of -11.53% (lower).

P/S

0.76

YoY

-11.53%

Last updated:

As of Aug 1, 2026, Option Care Health's P/S ratio stood at 0.76, a -11.53% change from the 0.86 P/S ratio recorded in the previous year.

The Option Care Health P/S history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/S
Date
P/S
Jan 1, 2019
1.14 base
Jan 1, 2020
0.92 base
Jan 1, 2021
1.52 base
Jan 1, 2022
1.40 base
Jan 1, 2023
1.39 base
Jan 1, 2024
0.79 base
Jan 1, 2025
0.90 base
Jan 1, 2026 (e)
0.67 base
YEARP/S
2026 est 0.67
2025 0.90
2024 0.79
2023 1.39
2022 1.40
2021 1.52
2020 0.92
2019 1.14
2018 1.18
2017 2.27
2016 0.65
2015 0.32
2014 1.35
2013 1.89
2012 2.69
2011 1.42
2010 1.71
2009 0.67
2008 0.16
2007 0.64
2006 0.29
Access this data via the Eulerpool API

Option Care Health Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Option Care Health's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Option Care Health's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Option Care Health's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Option Care Health grows earnings faster than its peers.

Option Care Health Stock analysis

What does Option Care Health do? Option Care Health Inc is a leading provider of specialized infusion therapies, hospital supplies, and home health care services. The company's headquarters are located in Bannockburn, Illinois. Established in 1979, Option Care has a long history of expansion and growth. In 1994, Option Care went public and in 2007, it received NASDAQ Global Select Market Listing Status. Option Care is divided into two main business segments: the Home Infusion Therapy segment and the Home Health Care segment. The Home Infusion Therapy segment offers a complete range of professional infusion therapies administered by specialized medical professionals. This segment also includes support services and products such as parenteral and enteral nutrition therapies, IV immunoglobulin, antibiotics, pain therapies, and other specialized medications. Option Care's Home Health Care segment provides a wide range of products and services for those in need of health care in their own homes. This includes nursing and rehabilitation services, equipment rental and sales, medical care and assistance, disease-related training programs, health monitoring and behavioral therapies, as well as infusion, wound care, and respiratory treatments. Option Care is committed to providing its patients with the best possible care and comprehensive services. The qualified medical professionals working for the company take a comprehensive approach to each patient, ensuring that each case is individually assessed and provided with optimized treatment. This personalized approach allows Option Care to consider the unique needs of each patient and ensures that every customer receives high-quality care with individualized support and assistance. Option Care works closely with physicians, clinics, and nursing facilities to ensure a seamless experience for patients in every phase of health care. The company takes a proactive approach to care and collaborates closely with each patient to develop and implement individualized treatment plans that focus on faster recovery and improved quality of life. Option Care Health Inc is a key player in the field of health care for patients in need of specialized infusion therapies and home health care services. The company has a long history of growth and expansion, which has enabled it to develop innovative treatment methods and better service offerings. Option Care's business models and product range provide patients with a variety of treatment options and high-quality service. Although Option Care has a broad reach, the company remains committed to individually caring for each patient and providing personalized attention. Option Care Health is one of the most popular companies on Eulerpool.

P/S Details

Decoding Option Care Health's P/S Ratio

Option Care Health's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Option Care Health's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Option Care Health's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Option Care Health’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Option Care Health stock

(Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. of Option Care Health is 0.76 in 2026.

The P/S ratio when valuing a stock.

The price-to-sales ratio (P/S ratio) is an important tool of technical analysis that assists investors in evaluating stocks. It refers to the earnings per share of a company and its price movements. This indicator can be used to determine a stock's fair value, relative to the company's earnings.

History of the Price-to-Sales Ratio

The price-to-sales ratio is a relatively new indicator. It was first used in the 1980s by John Price when he developed the Price-to-Sales Index (PSI). Price wanted to find a way to value stocks taking into account their earnings. He noticed that many stock prices were not in line with their earnings situation. The PSI has since become an important analytical tool and is often referred to as the P/S ratio.

Calculation of the price-to-sales ratio

The price-to-sales ratio is easy to calculate. It is determined by dividing the current stock price by the company's earnings per share. P/S ratio = Stock price / Earnings per share. For example, if a company's stock price is $10 and the earnings per share is $2, then the P/S ratio is 5.

Application of the Price-to-Sales Ratio

The Price-to-Sales ratio is a useful tool for determining a fairly valued stock price. A low P/S ratio may indicate that a stock price is undervalued, which could be a good entry opportunity. However, a high Price-to-Sales ratio may indicate that a stock price is overvalued and investors should exercise caution.

An example: A company has a stock price of 20 USD and an earnings per share of 2 USD. The P/E ratio is 10. This could indicate that the stock price is overvalued and investors should be cautious before buying.

Investors and the price-to-sales ratio

Investors use the price-to-sales ratio to determine whether a company's stock price is fairly valued or not. They can compare the P/S ratio to see how the stock price relates to the company's earnings. Investors can also observe the P/S ratio over a longer period of time to see if the stock price changes in relation to the company's earnings.

Advantages and Disadvantages of the Price-to-Sales Ratio

The greatest advantage of the price-to-sales ratio is that it is a simple and understandable tool to determine the fair value of a stock price. It can also help investors identify stocks that are undervalued. One disadvantage is that the P/S ratio does not provide information about the company's profits. Therefore, investors should also consider other financial ratios before investing.

In today's time, the price-to-sales ratio is an important tool for investors to evaluate stocks and identify potential investment opportunities. It can help find a fairly valued stock price and identify stocks that are undervalued. However, investors should also consider other financial indicators before making an investment decision.

Access this data via the Eulerpool API

Valuation — Option Care Health

All Key Metrics — Option Care Health